Q&A with Melanoma March Fundraisers
10 March 2015
Adrienne and Georgia lost their mother Patricia in 2009. They are taking part in this year's Melanoma March for the second time and hope that with their fundraising they can help another family go through what they had to. Read about how they are rallying their team together and hope to raise as much as possible.
Why are you taking part in this years Melanoma March?
We are taking part in this year's Melanoma March as we sadly lost our mother in 2009 to this aggressive disease. Mum first found her mole on the inside of year leg 14 years prior to her death. Adrienne was in year 1 and Georgia was in year 11. At the time, both of us didn’t quite comprehend the seriousness of her illness, nor did we expect that it would return some years later. Mum went into remission and in 2008 we discovered that the cancer had returned and was growing in her abdomen. After major surgery to remove the cancer we received the news that the cancer had spread to many of Mum’s organs. Within a few months it eventually reached her brain and Mum lost her battle. Our Mum wasn’t lucky enough to have the option of the trials and programs that are offered to melanoma patients now. Upon her first diagnosis in 1994 there were very limited options and when the cancer returned, it was too late for her. We are marching to raise awareness of melanoma in the hope that people avoid the harsh sun, understand the dangers of UV exposure and maintain regular skin check ups – whether they have had melanoma in the past, are predisposed to it or just need to keep an eye out for changes. In addition to raised awareness it is so important to continue to raise funds in order to fund important trials. We can only dream about what could have been a better outcome for our mother. Yet we hope that other individuals can get access to such valuable treatment that our mum couldn’t. If our fundraising can help the lives of another family to not go through what we did, we will do all we can.
How are you fundraising for your team?
We have contacted all our friends and families and asked them to march with us or make a donation to our team. Friends are holding morning teas at work to rally marchers and raise funds. Adrienne is a school teacher and will be sharing her story and having a guest speaker at her school this week.
How many people are in your team?
At present we have around 20 marchers who will be walking with us. We hope this number will continue to grow this week!
What are some of your tips to get your friends and family to donate?
The power of social media is great. We have been posting daily reminders to donate and register and set up a facebook event which we regularly update. Sending out SMS reminders has also been effective. We find that thanking people publicly on Facebook everytime we receive a donation helps to remind people as well as provide positive encouragement for others! We have asked members of our team to repost the link to register and donate. The last year our team marched in Manly we raised over $2000. We are close to $1000 at the moment and are pushing for more donations to come through this week. It would be amazing to match or beat our last effort. We find that most people donate in the week leading up to the event.
Donate now. Every bit counts towards a cure.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.